Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Avery Dennison | AVY | Nov 1, 2024 | 206.11 | -0.44 |
Axon Enterprise | AXON | Nov 1, 2024 | 425.84 | +0.55 |
Baker Hughes A | BKR | Nov 1, 2024 | 37.85 | -0.60 |
Ball | BALL | Nov 1, 2024 | 59.01 | -0.41 |
Bank Of America | BAC | Nov 1, 2024 | 41.76 | -0.14 |
Bank Of New York Mellon | BK | Nov 1, 2024 | 75.31 | -0.07 |
Baxter International | BAX | Nov 1, 2024 | 35.87 | +0.48 |
Becton, Dickinson And Co | BDX | Nov 1, 2024 | 235.24 | +0.71 |
Berkshire Hathaway B | BRK-B | Nov 1, 2024 | 452.14 | +0.27 |
Best Buy | BBY | Nov 1, 2024 | 90.90 | +0.52 |
Bio-Techne | TECH | Nov 1, 2024 | 75.31 | +2.12 |
Biogen | BIIB | Nov 1, 2024 | 173.79 | -0.12 |
BlackRock | BLK | Nov 1, 2024 | 985.08 | +0.41 |
Blackstone | BX | Nov 1, 2024 | 168.14 | +0.23 |
Boeing | BA | Nov 1, 2024 | 154.59 | +3.54 |
Booking | BKNG | Nov 1, 2024 | 4 749.11 | +1.56 |
BorgWarner | BWA | Nov 1, 2024 | 33.44 | -0.57 |
Boston Properties | BXP | Nov 1, 2024 | 79.16 | -1.74 |
Boston Scientific | BSX | Nov 1, 2024 | 83.62 | -0.48 |
Bristol-Myers Squibb | BMY | Nov 1, 2024 | 54.32 | -2.60 |
Broadcom | AVGO | Nov 1, 2024 | 168.92 | -0.50 |
Broadridge Financial Solutions | BR | Nov 1, 2024 | 210.21 | -0.31 |
Brown & Brown | BRO | Nov 1, 2024 | 104.17 | -0.45 |
Brown Forman B | BF-B | Nov 1, 2024 | 43.59 | -1.00 |
Builders Firstsource | BLDR | Nov 1, 2024 | 172.02 | +0.36 |
Bunge | BG | Nov 1, 2024 | 82.62 | -1.67 |
C.H. Robinson Worldwide | CHRW | Nov 1, 2024 | 101.82 | -1.18 |
Cadence Design Systems | CDNS | Nov 1, 2024 | 282.09 | +2.16 |
Caesars Entertainment | CZR | Nov 1, 2024 | 39.22 | -2.07 |
Camden Property Trust | CPT | Nov 1, 2024 | 113.73 | -1.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.